Fruquintinib: A Targeted Therapy for Advanced Metastatic Colorectal Cancer
An in-depth look at Fruquintinib, a novel oral treatment offering improved survival for mCRC patients.
Get a Quote & SampleProduct Core Value
Fruquintinib Powder
Fruquintinib is a significant advancement in the treatment of advanced metastatic colorectal cancer (mCRC), offering a targeted oral therapy that has demonstrated improved survival outcomes in clinical trials. As a multi-targeted tyrosine kinase inhibitor, it specifically inhibits VEGFR1, 2, and 3, playing a crucial role in managing cancer progression when other treatments have been exhausted.
- Explore the fruquintinib clinical trial results to understand its efficacy in treating advanced metastatic colorectal cancer.
- Discover the fruquintinib mechanism of action as a VEGFR inhibitor for CRC, showcasing its targeted approach.
- Learn about the fruquintinib indications and its role as a vital targeted therapy for metastatic colorectal cancer.
- Understand the fruquintinib side effects and management strategies crucial for patient care and treatment adherence.
Key Advantages
Improved Survival Outcomes
Clinical studies like FRESCO-2 highlight how fruquintinib for mCRC significantly extends overall survival, providing a crucial benefit for patients with previously treated advanced disease.
Convenient Oral Administration
As an oral treatment, Fruquintinib offers greater convenience for patients, allowing for at-home administration and potentially improving treatment adherence compared to intravenous therapies.
Targeted Molecular Approach
The precise targeting of VEGFR tyrosine kinases makes Fruquintinib a valuable option in precision medicine for colorectal cancer, addressing specific pathways involved in tumor growth.
Key Applications
Metastatic Colorectal Cancer (mCRC) Treatment
Fruquintinib is approved for adults with mCRC who have been previously treated with standard chemotherapy regimens, offering a new line of treatment.
Targeted Oncology Therapies
Its role as a VEGFR inhibitor positions Fruquintinib within the growing field of targeted therapies, aiming to disrupt cancer cell growth and survival mechanisms.
Advanced Cancer Drug Development
The ongoing research and successful trials in areas like fruquintinib oral treatment underscore its importance in the development of novel solutions for difficult-to-treat cancers.
Patient Quality of Life
Beyond efficacy, understanding fruquintinib side effects and management is key to maintaining patient quality of life, a crucial aspect of modern cancer care.